Sedat Ulkatan1, Milton Waner2, Beatriz Arranz-Arranz3, Inanna Weiss2, Theresa M J O2, Mehra Saral2, Vedran Deletis3, Alejandro Berenstein4. 1. Department of Intraoperative Neurophysiology, St Luke's Roosevelt Hospital, Mount Sinai Health System, New York, NY, USA. Electronic address: sulkatan@chpnet.org. 2. Vascular Birthmark Institute of New York, St Luke's Roosevelt Hospital, Mount Sinai Health System, New York, NY, USA. 3. Department of Intraoperative Neurophysiology, St Luke's Roosevelt Hospital, Mount Sinai Health System, New York, NY, USA. 4. Vascular Birthmark Institute of New York, St Luke's Roosevelt Hospital, Mount Sinai Health System, New York, NY, USA; Department of Interventional Neuroradiology at the Institute for Neurology and Neurosurgery, St Luke's Roosevelt Hospital, Mount Sinai Health System, New York, NY, USA.
Abstract
OBJECTIVE: To develop a more reliable methodology for monitoring the facial nerve in surgeries of vascular malformations where the extracranial segment of the nerve is at risk. METHODS: Our methodology comprises: (1) preoperative mapping to identify the anatomical location of the nerve branches, (2) continuous intraoperative monitoring of the compound muscle action potential (CMAP) by stimulating the facial nerve extracranially, in close proximity to where the trunk of the facial nerve exits the skull at the stylomastoid foramen, (3) intraoperative mapping to identify the nerve branches during surgical dissection and quantify the innervating contribution of each branch to the target muscle. RESULTS: Only three out of 201 surgeries (1.5%) had complete facial nerve trunk injury as a consequence of facial vascular malformation surgery. CONCLUSIONS: We developed a new method to continuously stimulate the facial nerve extracranially eliciting an objective parameter--the CMAP amplitude--to constantly measure changes in the muscle responses throughout surgery, alerting the surgeon before the facial nerve is severely injured. Our methodology notably reduces the complete facial nerve injury during extracranial surgery of facial vascular malformations. SIGNIFICANCE: This comprehensive methodology may also be a valuable tool to prevent facial nerve injury during other types of extracranial surgeries where radical excisions are required.
OBJECTIVE: To develop a more reliable methodology for monitoring the facial nerve in surgeries of vascular malformations where the extracranial segment of the nerve is at risk. METHODS: Our methodology comprises: (1) preoperative mapping to identify the anatomical location of the nerve branches, (2) continuous intraoperative monitoring of the compound muscle action potential (CMAP) by stimulating the facial nerve extracranially, in close proximity to where the trunk of the facial nerve exits the skull at the stylomastoid foramen, (3) intraoperative mapping to identify the nerve branches during surgical dissection and quantify the innervating contribution of each branch to the target muscle. RESULTS: Only three out of 201 surgeries (1.5%) had complete facial nerve trunk injury as a consequence of facial vascular malformation surgery. CONCLUSIONS: We developed a new method to continuously stimulate the facial nerve extracranially eliciting an objective parameter--the CMAP amplitude--to constantly measure changes in the muscle responses throughout surgery, alerting the surgeon before the facial nerve is severely injured. Our methodology notably reduces the complete facial nerve injury during extracranial surgery of facial vascular malformations. SIGNIFICANCE: This comprehensive methodology may also be a valuable tool to prevent facial nerve injury during other types of extracranial surgeries where radical excisions are required.
Authors: Randall A Bly; Robert N Holdefer; Jefferson Slimp; Gregory A Kinney; Vicente Martinez; Scott C Manning; Jonathan A Perkins Journal: JAMA Otolaryngol Head Neck Surg Date: 2018-05-01 Impact factor: 6.223
Authors: Petar Stankovic; Jan Wittlinger; Robert Georgiew; Nina Dominas; Katrin Reimann; Stephan Hoch; Thomas Wilhelm; Thomas Günzel Journal: Eur Arch Otorhinolaryngol Date: 2020-01-27 Impact factor: 2.503